ClinicalTrials.gov
public full text
Public Domain
Effect of Atorvastatin on Vascular Inflammation in Type 2 Diabetes
Type 2 diabetes mellitus significantly increases the risk for the development of atherosclerosis. Recently, atherosclerosis imaging with 18F-FDG PET (18F-Fluorodeoxyglucose Positron Emission Tomography) is useful for tracking inflammation within plaque and monitoring the response to drug therapy The purpose of this study is to determine whether FDG-PET is capable of detecting atherosclerotic vascular inflammation and monitoring the early effects of statins in type 2 diabetic patients. The usefulness of FDG-PET in risk stratification is also investigated.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- PET Imaging of Systemic Sclerosis Using FDG and 68Ga-DOTA-Siglec-9#898521
- Rho Kinase in Patients With Atherosclerosis#1086320
- Effect of Atorvastatin on Fractional Flow Reserve in Coronary Artery Disease#802524
- Probiotics for Vascular Inflammation in Metabolic Syndrome#841441
- Florbetaben for Imaging of Vascular Amyloid#893932
Record · ID 982420
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive